Drug name - Doryx
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6958161 | MAYNE PHARMA | Modified release coated drug preparation |
Dec, 2022
(2 months from now) | |
| US8715724 | MAYNE PHARMA | Tabletting process |
Feb, 2028
(5 years from now) | |
| US9295652 | MAYNE PHARMA | Controlled release doxycycline |
Oct, 2034
(12 years from now) | |
| US9511031 | MAYNE PHARMA | Controlled release doxycycline |
Oct, 2034
(12 years from now) | |
| US9446057 | MAYNE PHARMA | Controlled release doxycycline |
Dec, 2034
(12 years from now) | |
Drugs and Companies using DOXYCYCLINE HYCLATE ingredient
Treatment: To treat or prevent infections caused by susceptible bacteria using delayed-release tablets consisting of doxycycline hyclate coated pellets in a tablet
Dosage: TABLET, DELAYED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 50MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 75MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 80MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 100MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 150MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 200MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
| EQ 60MG BASE | TABLET, DELAYED RELEASE;ORAL | Discontinued |
| EQ 120MG BASE | TABLET, DELAYED RELEASE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.